HLA-DR/DQ Transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential

Biotherapy ◽  
1998 ◽  
Vol 10 (3) ◽  
pp. 191-196 ◽  
Author(s):  
Annemieke Geluk ◽  
Veena Taneja ◽  
Krista E. van Meijgaarden ◽  
René R. P. de Vries ◽  
Chella S. David ◽  
...  
2000 ◽  
Vol 165 (2) ◽  
pp. 1123-1137 ◽  
Author(s):  
Denise L. Doolan ◽  
Scott Southwood ◽  
Robert Chesnut ◽  
Ettore Appella ◽  
Eduardo Gomez ◽  
...  

1994 ◽  
Vol 93 (5) ◽  
pp. 891-899 ◽  
Author(s):  
J HIGGINS ◽  
C THORPE ◽  
J HAYBALL ◽  
R OHEHIR ◽  
J LAMB
Keyword(s):  
T Cell ◽  
Class Ii ◽  
Group I ◽  

2011 ◽  
Vol 21 ◽  
pp. e26-e27
Author(s):  
A. Rogel ◽  
V. Vignard ◽  
M. Bobinet ◽  
N. Labarrière ◽  
F. Lang
Keyword(s):  
T Cell ◽  
Class Ii ◽  

2008 ◽  
Vol 57 (8) ◽  
pp. 1185-1195 ◽  
Author(s):  
Junko Matsuzaki ◽  
Feng Qian ◽  
Immanuel Luescher ◽  
Shashikant Lele ◽  
Gerd Ritter ◽  
...  

2019 ◽  
Vol 8 (4) ◽  
pp. e1560919 ◽  
Author(s):  
Catherine Rabu ◽  
Laurie Rangan ◽  
Laetitia Florenceau ◽  
Agnès Fortun ◽  
Maud Charpentier ◽  
...  

Virology ◽  
2010 ◽  
Vol 408 (2) ◽  
pp. 232-240 ◽  
Author(s):  
Richard B. Kennedy ◽  
Gregory A. Poland

Vaccine ◽  
2009 ◽  
Vol 27 (34) ◽  
pp. 4718-4723 ◽  
Author(s):  
Matthias Piesche ◽  
York Hildebrandt ◽  
Björn Chapuy ◽  
Gerald G. Wulf ◽  
Lorenz Trümper ◽  
...  
Keyword(s):  
T Cell ◽  

2014 ◽  
Vol 21 (5) ◽  
pp. 641-650 ◽  
Author(s):  
Rachel M. Stenger ◽  
Hugo D. Meiring ◽  
Betsy Kuipers ◽  
Martien Poelen ◽  
Jacqueline A. M. van Gaans-van den Brink ◽  
...  

ABSTRACTKnowledge of naturally processedBordetella pertussis-specific T cell epitopes may help to increase our understanding of the basis of cell-mediated immune mechanisms to control this reemerging pathogen. Here, we elucidate for the first time the dominant major histocompatibility complex (MHC) class II-presentedB. pertussisCD4+T cell epitopes, expressed on human monocyte-derived dendritic cells (MDDC) after the processing of whole bacterial cells by use of a platform of immunoproteomics technology. Pertussis epitopes identified in the context of HLA-DR molecules were derived from two envelope proteins, i.e., putative periplasmic protein (PPP) and putative peptidoglycan-associated lipoprotein (PAL), and from two cytosolic proteins, i.e., 10-kDa chaperonin groES protein (groES) and adenylosuccinate synthetase (ASS). No epitopes were detectable from known virulence factors. CD4+T cell responsiveness in healthy adults against peptide pools representing epitope regions or full proteins confirmed the immunogenicity of PAL, PPP, groES, and ASS. Elevated lymphoproliferative activity to PPP, groES, and ASS in subjects within a year after the diagnosis of symptomatic pertussis suggested immunogenic exposure to these proteins during clinical infection. The PAL-, PPP-, groES-, and ASS-specific responses were associated with secretion of functional Th1 (tumor necrosis factor alpha [TNF-α] and gamma interferon [IFN-γ]) and Th2 (interleukin 5 [IL-5] and IL-13) cytokines. Relative paucity in the naturalB. pertussisepitope display of MDDC, not dominated by epitopes from known protective antigens, can interfere with the effectiveness of immune recognition ofB. pertussis. A more complete understanding of hallmarks inB. pertussis-specific immunity may advance the design of novel immunological assays and prevention strategies.


1994 ◽  
Vol 24 (9) ◽  
pp. 2213-2218 ◽  
Author(s):  
Amin Rahemtulla ◽  
Thomas M. Kündig ◽  
Arumugabadiv Narendran ◽  
Martin F. Bachmann ◽  
Michael Julius ◽  
...  

2016 ◽  
Vol 44 ◽  
pp. 182-189 ◽  
Author(s):  
Iti Saraav ◽  
Kirti Pandey ◽  
Monika Sharma ◽  
Swati Singh ◽  
Prasun Dutta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document